Evidence map›Paper›PMID 37786442›Full record

ReviewInternational journal of medical sciences2023

Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia-a Review.

Qin Zhu, Xuejun Cao, Yuan Zhang, Yuan Zhou, Jieying Zhang, Xiaofan Zhang, Yingting Zhu, Liping Xue

Open access · goldAbstract readReview
In one paragraph

Review in International journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Sustained Plus Lens Defocus Alters Retinal Responses and Ciliary Muscle Morphology In Myopes and Near-emmetropes.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Comparison of the efficacy and clinical applications of three different myopia control methods: repeated low-level red light, 1% atropine, and orthokeratology lenses in children and adolescent.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Management of myopia: a mini-review.Medical hypothesis, discovery & innovation ophthalmology journal · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Qin ZhuDepartment of Pediatric Ophthalmology, Affiliated Hospital of Yunnan University, Kunming 650021, China.
Xuejun CaoDepartment of Ophthalmology, the First Affiliated Hospital of Kunming Medical University, Kunming 650031, China.
Yuan ZhangBioTissue (Tissue Tech, Inc.), Ocular Surface Center, and Ocular Surface Research & Education Foundation, Miami, FL, 33126 USA.
Yuan ZhouDepartment of Pediatric Ophthalmology, Affiliated Hospital of Yunnan University, Kunming 650021, China.
Jieying ZhangDepartment of Pediatric Ophthalmology, Affiliated Hospital of Yunnan University, Kunming 650021, China.
Xiaofan ZhangDepartment of Pediatric Ophthalmology, Affiliated Hospital of Yunnan University, Kunming 650021, China.
Yingting ZhuBioTissue (Tissue Tech, Inc.), Ocular Surface Center, and Ocular Surface Research & Education Foundation, Miami, FL, 33126 USA.
Liping XueDepartment of Pediatric Ophthalmology, Affiliated Hospital of Yunnan University, Kunming 650021, China.
Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repeated low-level red-light (RLRL), characterized by increased energy supply and cellular metabolism, thus enhancing metabolic repair processes, has gained persistent worldwide attention in recent years as a new novel scientific approach for therapeutic application in myopia. This therapeutic revolution led by RLRL therapy is due to significant advances in bioenergetics and photobiology, for instance, enormous progresses in photobiomodulation regulated by cytochrome

Indexed as

Low-Level Light TherapyMyopiaDopamineHumansRefraction, OcularRetinaDopamine

Identifiers

PMID37786442
PMCPMC10542022
OpenAlexW4387098557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.